tirzepatide type 1 diabetes trial Efficacy and safety of a novel dual GIP and GLP-1 receptor agonist in patients with 2 (SURPASS-1): a double-blind, randomised, phase 3 Tirzepatide cuts risk of diabetes

This is not to say it is a wonder drug, though, as the National Library of Medicine notes, it has been known to cause tumors in lab animals, but it remains unclear if it causes a higher risk in humans

A.JaeschkeH.MarenziG.RicheldiL.et al

Glutathione and Alpha Arbutin penetrate to target melanin production deep within

Precautions During Treatment Monitor EPO Sensitivity: As anemia improves, the nephrology team must be prepared to down-titrate EPO doses to prevent polycythemia (excessively high red blood cell counts)

My levels had tanked since starting

Further exploration of management strategies can improve comfort during treatment